αvβ6 integrin is required for TGFβ1-mediated matrix metalloproteinase2 expression

Integrin  v 6 Promotes an Osteolytic Program in Cancer Cells by Upregulating MMP2

(2014) A. Dutta et al.   CANCER RESEARCH

Therapeutic Targeting of Integrin αvβ6 in Breast Cancer

(2014) Kate M. Moore et al.   JNCI-Journal of the National Cancer Institute

Trop-2 Promotes Prostate Cancer Metastasis By Modulating  1 Integrin Functions

(2013) M. Trerotola et al.   CANCER RESEARCH

Transforming growth factor-β1 treatment of oral cancer induces epithelial-mesenchymal transition and promotes bone invasion via enhanced activity of osteoclasts

(2013) Jingjing Quan et al.   CLINICAL & EXPERIMENTAL METASTASIS

Combination of Strong MMP-2 and Weak TIMP-2 Immunostainings Is a Significant Prognostic Factor in Endometrial Carcinoma

(2013) Maria Honkavuori-Toivola et al.   DISEASE MARKERS

Defining the Role of Integrin αvβ6 in Cancer

(2012) A. Bandyopadhyay et al.   CURRENT DRUG TARGETS

Integrin αvβ3 and CD44 pathways in metastatic prostate cancer cells support osteoclastogenesis via a Runx2/Smad 5/receptor activator of NF-κB ligand signaling axis

(2012) Aditi Gupta et al.   Molecular Cancer

TGF-β1 increases invasiveness of SW1990 cells through Rac1/ROS/NF-κB/IL-6/MMP-2

(2011) Marcelo G. Binker et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Altered TGF-β Signaling in a Subpopulation of Human Stromal Cells Promotes Prostatic Carcinogenesis

(2011) Omar E. Franco et al.   CANCER RESEARCH

Insulin-like growth factor 1 stimulation of androgen receptor activity requires β1A integrins

(2011) Aejaz Sayeed et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Differential roles of Smad2 and Smad3 in the regulation of TGF-β1-mediated growth inhibition and cell migration in pancreatic ductal adenocarcinoma cells: control by Rac1

(2011) Hendrik Ungefroren et al.   Molecular Cancer

SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression

(2011) Zhihu Ding et al.   NATURE

The TGF-β/Smad pathway induces breast cancer cell invasion through the up-regulation of matrix metalloproteinase 2 and 9 in a spheroid invasion model system

(2010) Eliza Wiercinska et al.   BREAST CANCER RESEARCH AND TREATMENT

Exogenous introduction of tissue inhibitor of metalloproteinase 2 reduces accelerated growth of TGF-β-disrupted diffuse-type gastric carcinoma

(2010) Erik Johansson et al.   CANCER SCIENCE

Collagen regulation of let-7 in pancreatic cancer involves TGF-β1-mediated membrane type 1-matrix metalloproteinase expression

(2010) S Dangi-Garimella et al.   ONCOGENE

Transforming growth factor-β induces CD44 cleavage that promotes migration of MDA-MB-435s cells through the up-regulation of membrane type 1-matrix metalloproteinase

(2009) Yi-Chih Kuo et al.   INTERNATIONAL JOURNAL OF CANCER

Runx2 association with progression of prostate cancer in patients: mechanisms mediating bone osteolysis and osteoblastic metastatic lesions

(2009) J Akech et al.   ONCOGENE

Antibody-Mediated Blockade of Integrin  v 6 Inhibits Tumor Progression In vivo by a Transforming Growth Factor- Regulated Mechanism

(2008) L. A. Koopman Van Aarsen et al.   CANCER RESEARCH

Integrin alphavbeta6 mediates the potential for colon cancer cells to colonize in and metastasize to the liver

(2008) Guang-Yun Yang et al.   CANCER SCIENCE

Roles of TGFβ in metastasis

(2008) David Padua et al.   CELL RESEARCH

Integrins in prostate cancer progression

(2008) H. L. Goel et al.   ENDOCRINE-RELATED CANCER

Overexpression of the αvβ6 Integrin in Endometrial Cancer

(2008) Jonathan L. Hecht et al.   APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY

Integrin α3β1 Potentiates TGFβ-Mediated Induction of MMP-9 in Immortalized Keratinocytes

(2007) John M. Lamar et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY